We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
We’re innovative thought leaders and determined advocates who partner with visionary organizations to change health care.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
In addition to being mission-driven, we contribute 5% of profits to charities that deliver health care to those in need.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
We're working to improve health for all, including enhancing quality, reducing costs, and expanding access to care.
The Wynne Health Group is the only mission-driven, public interest government relations firm focused on health and well-being.
OUR SERVICES
If you believe that every American deserves to be healthy and well, contact the Wynne Health Group to learn how our expertise can help you achieve your goals.
Policy Hub, managed by Wynne Health Group, is the only comprehensive database of Federal health policy developments, cataloged by over 200 healthcare topics and programs. Regulations, reimbursement, grants, ACA implementation, hearing summaries, CRS Reports, pending legislation – you get it all here, with comprehensive, expert analysis.
Final Rule Issued to Amend Definition of Biological Product; Aids Transition for Insulin as a Biologic
The Food and Drug Administration (FDA) issued a final rule to amend the definition of “biological product” to incorporate statutory changes and to provide an interpretation for the definition of a “protein.” In the accompanying press release, the FDA notes this final rule will ensure a smooth regulatory transition aimed at increasing patient access to insulin products and other biological… (Slifer, 2/20/20) #Biosimilars, #Food and Drug Administration, #Prescription Drugs
ONDCP, CDC Announce FY 2020 Drug-Free Communities Support Program Grant Opportunity; Due April 3
The White House Office of National Drug Control Policy (ONDCP), in partnership with the Centers for Disease Control and Prevention (CDC), recently issued a Notice of Funding Opportunity Announcement (FOA) for the fiscal year 2020 Drug-Free Communities (DFC) Support Program. The FOA is available to new coalitions (year 1 applicants) and competing continuations (year 6 applicants). The DFC Support Program… (Llamas, 2/19/20) #Mental and Behavioral Health, #Hospitals, #Pediatrics, #Physicians